Literature DB >> 15491037

Myopia and astigmatism in retinopathy of prematurity after treatment with cryotherapy or laser photocoagulation.

Abdullah Al-Ghamdi1, David A Albiani, William G Hodge, William N Clarke.   

Abstract

BACKGROUND: Visual outcome studies have shown that laser photocoagulation may result in more favourable clinical outcomes than cryotherapy in threshold retinopathy of prematurity (ROP). Comparative refractive outcome studies have shown that patients treated with laser photocoagulation have less myopia than those treated with cryotherapy. We carried out a study to determine whether a difference in visual outcome or refraction exists in patients with threshold ROP who have been treated with cryotherapy vs. laser photocoagulation.
METHODS: A retrospective cohort study was conducted comparing treatment results after at least 3 years of follow-up in patients with threshold ROP treated with cryotherapy or laser photocoagulation at a tertiary care children's hospital. Visual acuity and refraction were the outcomes studied. Covariates measured were sex, gestational age and birth weight. Analysis was performed with both bivariate analysis and multivariate models.
RESULTS: Seventy-one eyes of 37 patients with threshold ROP were included in the study. Thirty-seven eyes received cryotherapy, and 34 eyes received laser photocoagulation. The mean spherical equivalent refraction was significantly lower in the cryotherapy group than in the laser photocoagulation group (-9.21 dioptres vs. -1.80 dioptres, p = 0.001). Patients in the cryotherapy group were more likely than those in the laser photocoagulation group to have against-the-rule astigmatism (odds ratio 6.86, p = 0.004). Laser photocoagulation did not significantly lower the frequency of an unfavourable visual outcome (visual acuity worse than 20/200) (p = 0.09).
INTERPRETATION: Eyes with threshold ROP treated with laser photocoagulation were significantly less myopic and less likely to have against-the-rule astigmatism than those treated with cryotherapy.

Entities:  

Mesh:

Year:  2004        PMID: 15491037     DOI: 10.1016/s0008-4182(04)80142-x

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  7 in total

Review 1.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

2.  Astigmatism and biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age.

Authors:  C-S Yang; A-G Wang; Y-F Shih; W-M Hsu
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

3.  Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age.

Authors:  Bradley V Davitt; Velma Dobson; Graham E Quinn; Robert J Hardy; Betty Tung; William V Good
Journal:  Ophthalmology       Date:  2008-12-16       Impact factor: 12.079

4.  Effect of peripheral retinal ablation with cryotherapy versus diode laser photocoagulation on axial length in the growing rabbit eye.

Authors:  R Axer-Siegel; D Bourla; I Kremer; D Weinberger; M Snir
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

5.  Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity.

Authors:  Parag K Shah; Minu Ramakrishnan; Bani Sadat; Sandeep Bachu; V Narendran; N Kalpana
Journal:  Oman J Ophthalmol       Date:  2014-09

6.  Retinopathy of prematurity: a review of epidemiology and current treatment strategies.

Authors:  Eun Hee Hong; Yong Un Shin; Heeyoon Cho
Journal:  Clin Exp Pediatr       Date:  2021-10-12

7.  Structural and functional results of indirect diode laser treatment for retinopathy of prematurity from 1999 to 2003 in Kuwait.

Authors:  Vivek B Wani; Khalid Al Sabti; Niranjan Kumar; Seemant Raizada; Jamal Al Kandari; Mohammad Al Harbi; Rima Sawaan; Usha Rajaram; Niran Al-Naqeeb; Mumtaz Shukkur
Journal:  Clin Ophthalmol       Date:  2013-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.